SCHEMBL2490157

SCHEMBL2490157

CC(C)(C)OC(=O)NCCc1cc(C(=O)O)no1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 4/20 0.53
HDAC1 Q13547 2/20 0.53
HTT P42858 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NR1H4 Q96RI1 2/20 0.44
NQO2 P16083 1/20 0.42
ALDH1A1 P00352 3/20 0.41
GFER P55789 1/20 0.41
GAA P10253 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
MAPT P10636 2/20 0.40
MAPK1 P28482 1/20 0.40
POLB P06746 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1810190 0.86 NR1H4 (0.45) HDAC6HDAC1NPC1RAB9ASMN1; SMN2
SCHEMBL29828819 0.83 HDAC6 (0.49) HDAC6HDAC1HTTNPSR1SMN1; SMN2
SCHEMBL29798919 0.79 TDP1 (0.48) HDAC6HDAC1HTTNPSR1SMN1; SMN2
SCHEMBL2411780 0.77 NPSR1 (0.44) HTTNPSR1NQO2ALDH1A1GFER
SCHEMBL3884335 0.77 HTT (0.44) HDAC6HDAC1HTTNPSR1SMN1; SMN2
SCHEMBL28231777 0.75 HTT (0.47) HDAC6HDAC1HTTNPSR1SMN1; SMN2
SCHEMBL18764998 0.75 HTT (0.50) HTTNPSR1SMN1; SMN2NQO2ALDH1A1
SCHEMBL21639067 0.74 CTSS (0.43) HDAC6HDAC1NPC1RAB9ATDP1
SCHEMBL21639064 0.74 CTSS (0.43) HDAC6HDAC1NPC1RAB9ATDP1
SCHEMBL4010124 0.74 NR1H4 (0.44) HDAC6HDAC1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379513-A1 HETEROARYL COMPOUNDS USEFUL AS RAF KINASE INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-10-26 EP disclosed
WO-2010078408-A1 HETEROARYL COMPOUNDS USEFUL AS RAF KINASE INHIBITORS BIOGEN IDEC MA INC. (US) 2010-07-08 WO disclosed
EP-2167489-A2 PYRIMIDINE DERIVATIVES USEFUL AS RAF KINASE INHIBITORS Sunesis Pharmaceuticals, Inc. (US) 2010-03-31 EP disclosed
EP-2167497-A2 HETEROCYCLIC COMPOUNDS USEFUL AS RAF KINASE INHIBITORS Sunesis Pharmaceuticals, Inc. (US) 2010-03-31 EP disclosed
WO-2009006404-A2 HETEROCYCLIC COMPOUNDS USEFUL AS RAF KINASE INHIBITORS SUNESIS PHARMACEUTICALS, INC. (US) 2009-01-08 WO disclosed
WO-2009006389-A2 PYRIMIDINE DERIVATIVES USEFUL AS RAF KINASE INHIBITORS SUNESIS PHARMACEUTICALS, INC. (US) 2009-01-08 WO disclosed